Company Filing History:
Years Active: 2020
Title: Douglas Bryan Burtrum: Innovator in Canine Health
Introduction
Douglas Bryan Burtrum is a notable inventor based in New York, NY (US). He has made significant contributions to the field of veterinary medicine, particularly through his innovative work on antibodies.
Latest Patents
Burtrum holds a patent for an "Anti-canine platelet derived growth factor receptor alpha antibody." This patent relates to antibodies that bind to the canine platelet derived growth factor receptor alpha, which has implications for canine health and treatment.
Career Highlights
Burtrum is associated with Elanco US Inc., a company dedicated to animal health. His work at Elanco focuses on developing solutions that enhance the well-being of animals, showcasing his commitment to veterinary advancements.
Collaborations
Throughout his career, Burtrum has collaborated with esteemed colleagues, including Dale Lincoln Ludwig and Juqun Shen. These partnerships have fostered innovation and contributed to the development of effective veterinary treatments.
Conclusion
Douglas Bryan Burtrum exemplifies the spirit of innovation in the field of veterinary medicine. His contributions through patents and collaborations continue to impact canine health positively.